2019-2020 Session
Change SessionH.162
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
- Sponsor(s)
- Last Recorded Action
- House 6/3/2020 - Ordered to Lie upon motion of Rep. Grad of Moretown
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Detailed Status
Regular Session 2019-2020
Body | Date | Journal | Calendar | Location | Full Status |
---|
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Roll Call History
Regular Session 2019-2020
Body | Date | Journal | Location | Full Status |
---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Committee Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Meeting Full List
Regular Session 2019-2020
Thursday, February 14, 2019
- Committee(s):
- House Committee on Judiciary
- 11:00 AM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Sarah George, Deputy State's Attorney, Chittenden County
Thursday, February 28, 2019
- Committee(s):
- House Committee on Judiciary
- 9:00 AM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Walk-through and Testimony
Michele Childs, Legislative Counsel, Office of Legislative Counsel
David Cahill, State's Attorney, Windsor County
David Scherr, Assistant Attorney General, Vermont Attorney General's Office
James Pepper, Deputy State's Attorney, Department of State's Attorneys & Sheriffs
Casey Daniell, Lieutenant, Department of Public Safety
Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
Thursday, March 14, 2019
- Committee(s):
- House Committee on Judiciary
- 15 Minutes After Floor
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Testimony, Committee Discussion and Possible Vote
Brandon del Pozo , Chief of Police, Burlington Police Department
Matthew Prouty, Commander, Rutland Police Department
Friday, March 15, 2019
- Committee(s):
- House Committee on Judiciary
- 15 Minutes After Floor
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Committee Discussion and Possible Vote
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Wednesday, March 27, 2019
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Rep. Martin LaLonde, Reporter
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Timothy Shafer, Townshend, Vermont
Friday, March 29, 2019
- Committee(s):
- House Committee on Human Services
- 1:30 PM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Mark Levine, Commissioner, Vermont Department of Health
Shayla Livingston, Public Health Policy Advisor, Department of Health
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Jamie Woll, Williston
Wednesday, April 3, 2019
- Committee(s):
- House Committee on Human Services
- -
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Deborah Richter, MD, Family Physician and Addiction Medicine Specialist
Christopher Lukonis, Gifford Addiction Medicine, Kingwood Health Center, Randolph
Thursday, April 25, 2019
- Committee(s):
- House Committee on Human Services
- 10:30 AM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Kimberly Blake, Physician, Burlington
David Hall, Legislative Counsel, Office of Legislative Counsel
Shayne Lynn, Executive Director, Champlain Valley Dispensary, Inc.
Shayla Livingston, Public Health Policy Advisor, Department of Health
Rep. John Gannon, House Committee On Government Operations
Jeffrey Wallin, Director, Vermont Information Crime Center (VCIC)
- 15 mins after Floor adjourns
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Rep. John Gannon, House Committee On Government Operations
Shayne Lynn, Executive Director, Champlain Valley Dispensary, Inc.
Shayla Livingston, Public Health Policy Advisor, Department of Health
Jeffrey Wallin, Director, Vermont Information Crime Center (VCIC)
Tuesday, April 30, 2019
- Committee(s):
- House Committee on Human Services
- 3:30 PM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Joshua Scharfstein, Professor of the Practice in Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
Noa Krawcyzk, 4th Year Doctoral Candidate, John Hopkins Bloomberg School of Public Health
Friday, May 3, 2019
- Committee(s):
- House Committee on Human Services
- 1:00 PM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Tony Folland, Clinical Services Manager and State Opioid Treatment Authority, Department of Health
Mark Levine, Commissioner, Vermont Department of Health
Anthony Zarriello, Clinical Consultant, Washington County Treatment Court, Clinical Director, Treatment Associates, Montpelier and Morrisville
Wednesday, January 22, 2020
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Kate O'Neill, Freelance Writer
Steve Leffler, President, University of Vermont Medical Center, Vermont Medical Society President
Grace Keller, Safe Recovery Program Coordinator, Howard Center
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Wednesday, March 11, 2020
- Committee(s):
- House Committee on Human Services
- 15 mins after Floor
-
H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Mark-up and vote
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Committee Documents
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Witnesses Who Testified
Regular Session 2019-2020
House Committee on Human Services
- Noa Krawcyzk, 4th Year Doctoral Candidate, John Hopkins Bloomberg School of Public Health
- Kimberly Blake, Physician, Burlington
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Tony Folland, Clinical Services Manager and State Opioid Treatment Authority, Department of Health
- Rep. John Gannon, House Committee On Government Operations
- David Hall, Legislative Counsel, Office of Legislative Counsel
- Grace Keller, Safe Recovery Program Coordinator, Howard Center
- Rep. Martin LaLonde, Reporter
- Steve Leffler, President, University of Vermont Medical Center, Vermont Medical Society President
- Mark Levine, Commissioner, Vermont Department of Health
- Shayla Livingston, Public Health Policy Advisor, Department of Health
- Christopher Lukonis, Gifford Addiction Medicine, Kingwood Health Center, Randolph
- Shayne Lynn, Executive Director, Champlain Valley Dispensary, Inc.
- Kate O'Neill, Freelance Writer
- Deborah Richter, MD, Family Physician and Addiction Medicine Specialist
- Joshua Scharfstein, Professor of the Practice in Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
- Timothy Shafer, Townshend, Vermont
- Jeffrey Wallin, Director, Vermont Information Crime Center (VCIC)
- Jamie Woll, Williston
- Anthony Zarriello, Clinical Consultant, Washington County Treatment Court, Clinical Director, Treatment Associates, Montpelier and Morrisville
House Committee on Judiciary
- David Cahill, State's Attorney, Windsor County
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
- Casey Daniell, Lieutenant, Department of Public Safety
- Brandon del Pozo , Chief of Police, Burlington Police Department
- Sarah George, Deputy State's Attorney, Chittenden County
- James Pepper, Deputy State's Attorney, Department of State's Attorneys & Sheriffs
- Matthew Prouty, Commander, Rutland Police Department
- David Scherr, Assistant Attorney General, Vermont Attorney General's Office
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.162 in the Regular Session 2019-2020.
No committee of conference members found for H.162 in the Regular Session 2019-2020.
An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic
Committee of Conference Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|